Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients

NCT02184299 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Nevirapine
DRUG: Prednisone

Sponsor

Boehringer Ingelheim